Nu-Med Plus (NUMD) Return on Equity Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Nu-Med Plus | - | - | - | -1.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | -1.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -3.00 |
| Dec 31, 2024 | -8.00 |
| Sep 30, 2024 | -34.00 |
| Jun 30, 2024 | 17.00 |
| Mar 31, 2024 | 8.00 |
| Dec 31, 2023 | 7.00 |
| Sep 30, 2023 | 6.00 |
| Jun 30, 2023 | 65.00 |
| Mar 31, 2023 | -1.00 |
| Dec 31, 2022 | -2.00 |
| Sep 30, 2022 | -3.00 |
| Jun 30, 2022 | -4.00 |
| Mar 31, 2022 | -13.00 |
| Dec 31, 2021 | 18.00 |
| Sep 30, 2021 | -2.00 |
| Jun 30, 2021 | 135.00 |
| Mar 31, 2021 | -156.00 |
| Dec 31, 2020 | -69.00 |
| Sep 30, 2020 | 19.00 |
| Jun 30, 2020 | -63.00 |
| Mar 31, 2020 | 2.00 |
| Dec 31, 2019 | 3.00 |
| Sep 30, 2019 | 4.00 |
| Jun 30, 2019 | 4.00 |
| Mar 31, 2019 | 16.00 |
| Dec 31, 2018 | -10.00 |
| Sep 30, 2018 | 30.00 |
| Jun 30, 2018 | -158.00 |
| Mar 31, 2018 | 149.00 |
| Dec 31, 2017 | 63.00 |
| Sep 30, 2017 | -19.00 |
| Jun 30, 2017 | 0.00 |
| Mar 31, 2017 | 3.00 |
| Dec 31, 2016 | -1.00 |
| Sep 30, 2016 | -3.00 |
| Jun 30, 2016 | -1.00 |
| Mar 31, 2016 | -4.00 |